Epstein-Barr virus-related lymphoproliferative disorder, cytomegalovirus reactivation, and varicella zoster virus encephalitis during treatment of medulloblastoma

Journal of Medical Virology

Volumn 83, Issue 9, 2011, Pages 1582-1584

  Ohta, Motoki ^a   Taga, Takashi ^a   Nomura, Akitaka ^a   Kato, Hirofumi ^a   Takano, Tomoyuki ^a   Maruo, Yoshihiro ^a   Takeuchi, Yoshihiro ^a   Ishida, Mitsuaki ^a   Ohta, Shigeru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Co infection; Herpes virus; Non transplant setting

Indexed keywords

ACICLOVIR; CD20 ANTIBODY; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOMEGALOVIRUS ANTIGEN PP65; DEXAMETHASONE; ETOPOSIDE; GANCICLOVIR; METHOTREXATE; RITUXIMAB; STEROID; VINCRISTINE;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BODY RASH; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COLON DISEASE; COLONOSCOPY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG ERUPTION; DRUG FEVER; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FACE RASH; FEMALE; GASTROSCOPY; HERPES ZOSTER ENCEPHALITIS; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; RADIATION DOSE; STOMACH DISEASE; STOMACH LESION; TOTAL PARENTERAL NUTRITION; VIRUS REACTIVATION; VOMITING;

ACYCLOVIR; ADOLESCENT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIVIRAL AGENTS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CYTOMEGALOVIRUS INFECTIONS; ENCEPHALITIS, VARICELLA ZOSTER; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GANCICLOVIR; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; LYMPHOPENIA; LYMPHOPROLIFERATIVE DISORDERS; MEDULLOBLASTOMA; VIRUS ACTIVATION;

CYTOMEGALOVIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4;

EID: 79960147712     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22136     Document Type: Article

References (10)

1. Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K. 1998. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol 56: 186-191.
2. Fishman JA, Emery V, Freeman R, Pascual M, Rostaing L, Schlitt HJ, Sgarabotto D, Torre-Cisneros J, Uknis ME. 2007. Cytomegalovirus in transplantation-Challenging the status quo. Clin Transplant 21: 149-158.
3. Freigassner P, Ardjomand N, Radner H, El-Shabrawi Y. 2002. Coinfection of the retina by Epstein-Barr virus and cytomegalovirus in an AIDS patient. Am J Ophthalmol 134: 275-277.
4. Hasserjian RP, Chen S, Perkins SL, Leva L, Kinney MC, Barry TS, Said J, Lim MS, Finn WG, Medeiros LJ, Harris NL, O'Malley DP. 2009. Immunomodulator agent-related lymphoproliferative disorders. Mod Pathol 22: 1532-1540.
5. Johnston A, Salloes G, Espinouse D, Felman P, Andre P, Berger F, Coiffier B. 2008. Epstein-Barr virus-induced lymphoproliferative disorder after rituximab combined with CHOP therapy. Clin Lymphoma Myeloma 8: 356-358.
6. Kawa H. 2000. Epstein-Barr virus-associated disease in humans. Int J Hematol 1: 108-117.
7. Kamel OW. 1997. Iatrogenic lymphproliferative disorders in nontransplantation setting. Semin Diagn Pathol 14: 27-34.
8. Lee DA, Tatevian N, Herring RA, McClain KL. 2008. EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH. Pediatr Blood Cancer 50: 728-730.
9. Oill O, Fiala M, Schoffman J, Byfield P, Guze L. 1977. Cytomegalovirus mononucleosis in healthy adult: Association with hepatitis, secondary Epstein-Barr virus antibody response and immunosuppression. Am J Med 62: 413-417.
10. Syrjanen S, Leimola-Virtanen R, Schmidt-Westhausen A, Reichart PA. 1999. Oral ulcers in AIDS patients frequently associated with cytomegalovirus and Epstein-Barr virus infection. J Oral Pathol Med 28: 204-209.